Related Experiment Videos
p53 gene mutations in pediatric brain tumors
1Division of Oncology, Children's Hospital of Philadelphia, PA 19104, USA.
Medical and Pediatric Oncology
|December 1, 1995
Summary
p53 mutations are rare in pediatric brain tumors, particularly low-grade astrocytomas and primitive neuroectodermal tumors (PNETs). Mutations were found in glioblastomas (GBMs), suggesting different molecular pathways in pediatric gliomas.
Area of Science:
- Oncology
- Molecular Biology
- Pediatric Neurology
Background:
- The p53 tumor suppressor gene is crucial in preventing cancer.
- Understanding p53 mutation patterns in pediatric brain tumors is vital for diagnosis and treatment.
Purpose of the Study:
- To determine the frequency and spectrum of p53 mutations in various pediatric brain tumor subtypes.
- To compare p53 mutation profiles between pediatric and adult brain tumors.
Main Methods:
- Analysis of 47 pediatric brain tumors across diverse histologic types.
- p53 exons 4-8 mutation detection using single-strand conformation polymorphism (SSCP) and sequencing.
Main Results:
- p53 mutations were identified in 2 out of 3 pediatric glioblastomas (GBMs).
- No p53 mutations were found in 17 pediatric low-grade astrocytomas (p=0.02).
- One primitive neuroectodermal tumor (PNET) showed a somatic p53 mutation.
Conclusions:
- p53 mutations are infrequent in most pediatric brain tumors, including PNETs and low-grade astrocytomas.
- In pediatric gliomas, p53 mutations appear specific to glioblastomas (GBMs).
- Distinct molecular pathogenesis likely exists between adult and pediatric gliomas, evidenced by p53 mutation differences.